Raleigh Capital Management Inc. Astrazeneca PLC Transaction History
Raleigh Capital Management Inc.
- $232 Million
- Q2 2024
A detailed history of Raleigh Capital Management Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 812 shares of AZN stock, worth $62,905. This represents 0.03% of its overall portfolio holdings.
Number of Shares
812
Previous 795
2.14%
Holding current value
$62,905
Previous $53,000
18.87%
% of portfolio
0.03%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...